Basic information Safety Supplier Related

DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE

Basic information Safety Supplier Related

DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Basic information

Product Name:
DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE
Synonyms:
  • DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE
  • 5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3-[(2-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-1-benzopyrylium chloride
  • Delphinidin 3-sambubioside chloride
  • DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE(RG)
  • delphinidin 3-O-beta-D-sambubioside
  • Delphinidin 3-Sambubioside
  • DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE USP/EP/BP
  • delphinidin 3-O-β-D-sambubioside
CAS:
53158-73-9
MF:
C26H29O16.Cl
MW:
632.952
Mol File:
53158-73-9.mol
More
Less

DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Chemical Properties

storage temp. 
-20°C
solubility 
Soluble in methan
form 
powder
color 
Dark, reddish
More
Less

DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDE Usage And Synthesis

Uses

Delphinidin 3-sambubioside chloride may be used as an analytical standard for the determination of the analyte in calyces of Hibiscus sabdariffa flowers by high performance liquid chromatography (HPLC) technique.

Definition

ChEBI: An anthocyanidin 3-O-beta-D-sambubioside having delphinidin as the anthocyanidin component.

General Description

This substance is supplied with certified chromatographic purity. The exact value can be found on the certificate. Produced by PhytoLab GmbH & Co. KG

in vivo

Delphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) inhibits mouse paw edema induced by LPS[1].
Delphinidin-3-sambubioside chloride (30 mg/kg body, oral gavage, daily for eight weeks) decreases lipid accumulation in HFD rats[3].

Animal Model:Delphinidin-3-sambubioside chloride (15 μmol/kg, i.p.) Inhibit LPS-induced paw edema in mice[1].
Delphinidin-3-sambubioside chloride (30 mg/kg body,Gavage once daily for eight weeks to reduce lipid accumulation in HFD rats[3]
Dosage:15 μmol/kg
Administration:Intraperitoneal injection (i.p.), for 4 days.
Result:Reduced the LPS-induced paw thickness.
Decreased the edema by 89.3%.
Decreased the levels of LPS induced serum IL-6, MCP-1 and TNF-α.
Animal Model:HFD-fed rats[3]
Dosage:30 mg/kg
Administration:Oral gavage, daily for eight weeks.
Result:Reduced the body weight gain, visceral fat, and abdominal fat and decreased hepatic lipid deposits.

target

ROS

DELPHINIDIN-3-O-SAMBUBIOSIDE CHLORIDESupplier

Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
ALB Technology Limited
Tel
702-983-3769
Email
sales@albtechnology.com